Biogen resurrects Alzheimer's drug, stock soars

First published at 17:54 UTC on October 22nd, 2019.

Reuters News



Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will seek approval for an Alzheimer's treatment after abandoning the drug earlier this year. Freddie Joyner has the story.

CategoryNews & Politics
SensitivityNormal - Content that is suitable for ages 16 and over